➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Moodys
Dow
Colorcon
Mallinckrodt

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Rifampin - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for rifampin and what is the scope of freedom to operate?

Rifampin is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Akorn, Lannett Co Inc, Lupin Pharms, Sandoz, Oxford Pharms, Emcure Pharms Ltd, Fresenius Kabi Usa, Hikma Pharms, Mylan Labs Ltd, Watson Pharms Teva, and West-ward Pharms Int, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for rifampin. Sixteen suppliers are listed for this compound.

Drug Prices for rifampin

See drug prices for rifampin

Recent Clinical Trials for rifampin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Texas Southwestern Medical CenterPhase 2
Odonate Therapeutics, Inc.Phase 1
Fifth Affiliated Hospital, Sun Yat-Sen UniversityN/A

See all rifampin clinical trials

Pharmacology for rifampin

US Patents and Regulatory Information for rifampin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms RIFAMPIN rifampin INJECTABLE;INJECTION 205039-001 Mar 3, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc RIFAMPIN rifampin CAPSULE;ORAL 065390-002 Mar 28, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc RIFAMPIN rifampin CAPSULE;ORAL 065390-001 Mar 28, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Sanofi Aventis Us RIFADIN rifampin CAPSULE;ORAL 062303-001 Approved Prior to Jan 1, 1982 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Colorcon
Mallinckrodt
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.